{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:51:50Z","timestamp":1791147110881,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:00:00Z","timestamp":1791072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:00:00Z","timestamp":1791072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272777"],"award-info":[{"award-number":["82272777"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471153"],"award-info":[{"award-number":["82471153"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403589"],"award-info":[{"award-number":["82403589"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2025ZNSFSC1528"],"award-info":[{"award-number":["2025ZNSFSC1528"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2025ZNSFSC1530"],"award-info":[{"award-number":["2025ZNSFSC1530"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chengdu Science and Technology Bureau","award":["2024-YF05-00908-SN"],"award-info":[{"award-number":["2024-YF05-00908-SN"]}],"id":[{"id":"https:\/\/ror.org\/00xfea068","id-type":"ROR","asserted-by":"crossref"}]},{"name":"1\u00b73\u00b75 project for disciplines of excellence-Clinical Research Fund, West China Hospital, Sichuan University","award":["2025HXFH010"],"award-info":[{"award-number":["2025HXFH010"]}]},{"name":"1\u00b73\u00b75 project for disciplines of excellence, West China Hospital, Sichuan University","award":["2025-522"],"award-info":[{"award-number":["2025-522"]}],"id":[{"id":"https:\/\/ror.org\/011ashp19","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Sichuan University Interdisciplinary Innovation Fund","id":[{"id":"https:\/\/ror.org\/011ashp19","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"DOI":"10.1007\/s00405-026-10663-5","type":"journal-article","created":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:58:39Z","timestamp":1791143919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic susceptibility, risk prediction, and druggable targets for oropharyngeal cancer: a UK Biobank study"],"prefix":"10.1007","author":[{"given":"Junhong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufang","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanhuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5938-688X","authenticated-orcid":false,"given":"Jianjun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,4]]},"reference":[{"issue":"5","key":"10663_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","volume":"19","author":"M Lechner","year":"2022","unstructured":"Lechner M, Liu J, Masterson L, Fenton TR (2022) HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nat Rev Clin Oncol 19(5):306\u2013327. https:\/\/doi.org\/10.1038\/s41571-022-00603-7","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"10663_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"10663_CR3","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/jnci\/djad169","volume":"115","author":"ZS Zumsteg","year":"2023","unstructured":"Zumsteg ZS, Luu M, Rosenberg PS, Elrod JK, Bray F, Vaccarella S et al (2023) Global epidemiologic patterns of oropharyngeal cancer incidence trends. J Natl Cancer Inst 115(12):1544\u20131554. https:\/\/doi.org\/10.1093\/jnci\/djad169","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10663_CR4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/ijc.23848","volume":"124","author":"E Negri","year":"2009","unstructured":"Negri E, Boffetta P, Berthiller J, Castellsague X, Curado MP, Dal Maso L et al (2009) Family history of cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Int J Cancer 124(2):394\u2013401. https:\/\/doi.org\/10.1002\/ijc.23848","journal-title":"Int J Cancer"},{"issue":"21","key":"10663_CR5","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/jnci\/86.21.1600","volume":"86","author":"DE Goldgar","year":"1994","unstructured":"Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86(21):1600\u20131608. https:\/\/doi.org\/10.1093\/jnci\/86.21.1600","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10663_CR6","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1002\/ijc.31530","volume":"143","author":"Y Tao","year":"2018","unstructured":"Tao Y, Sturgis EM, Huang Z, Sun Y, Dahlstrom KR, Wei Q et al (2018) A TGF-\u03b21 genetic variant at the miRNA187 binding site significantly modifies risk of HPV16-associated oropharyngeal cancer. Int J Cancer 143(6):1327\u20131334. https:\/\/doi.org\/10.1002\/ijc.31530","journal-title":"Int J Cancer"},{"issue":"4","key":"10663_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1158\/1940-6207.capr-18-0449","volume":"12","author":"HT Chien","year":"2019","unstructured":"Chien HT, Young CK, Chen TP, Liao CT, Wang HM, Cheng SD et al (2019) Alcohol-metabolizing enzymes\u2019 gene polymorphisms and susceptibility to multiple head and neck cancers. Cancer Prev Res (Phila) 12(4):247\u2013254. https:\/\/doi.org\/10.1158\/1940-6207.capr-18-0449","journal-title":"Cancer Prev Res (Phila)"},{"issue":"12","key":"10663_CR8","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/ng.3685","volume":"48","author":"C Lesseur","year":"2016","unstructured":"Lesseur C, Diergaarde B, Olshan AF, W\u00fcnsch-Filho V, Ness AR, Liu G et al (2016) Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer. Nat Genet 48(12):1544\u20131550. https:\/\/doi.org\/10.1038\/ng.3685","journal-title":"Nat Genet"},{"issue":"1","key":"10663_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26151-9","volume":"12","author":"A Ferreiro-Iglesias","year":"2021","unstructured":"Ferreiro-Iglesias A, McKay JD, Brenner N, Virani S, Lesseur C, Gaborieau V et al (2021) Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer. Nat Commun 12(1):5945. https:\/\/doi.org\/10.1038\/s41467-021-26151-9","journal-title":"Nat Commun"},{"issue":"12","key":"10663_CR10","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1158\/0008-5472.Can-19-2360","volume":"80","author":"S Shete","year":"2020","unstructured":"Shete S, Liu H, Wang J, Yu R, Sturgis EM, Li G et al (2020) A genome-wide association study identifies two novel susceptible regions for squamous cell carcinoma of the head and neck. Cancer Res 80(12):2451\u20132460. https:\/\/doi.org\/10.1158\/0008-5472.Can-19-2360","journal-title":"Cancer Res"},{"issue":"1","key":"10663_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63842-z","volume":"16","author":"E Ebrahimi","year":"2025","unstructured":"Ebrahimi E, Sangphukieo A, Park HA, Gaborieau V, Ferreiro-Iglesias A, Diergaarde B et al (2025) Cross-ancestral GWAS identifies 29 variants across head and neck cancer subsites. Nat Commun 16(1):8787. https:\/\/doi.org\/10.1038\/s41467-025-63842-z","journal-title":"Nat Commun"},{"issue":"1","key":"10663_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1001\/jamaoncol.2018.4051","volume":"5","author":"E Massarelli","year":"2019","unstructured":"Massarelli E, William W, Johnson F, Kies M, Ferrarotto R, Guo M et al (2019) Combining immune checkpoint blockade and tumor-specific vaccine for patients with incurable human papillomavirus 16-related cancer: a phase 2 clinical trial. JAMA Oncol 5(1):67\u201373. https:\/\/doi.org\/10.1001\/jamaoncol.2018.4051","journal-title":"JAMA Oncol"},{"issue":"13","key":"10663_CR13","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1158\/1078-0432.Ccr-19-3977","volume":"26","author":"R Ferrarotto","year":"2020","unstructured":"Ferrarotto R, Bell D, Rubin ML, Hutcheson KA, Johnson JM, Goepfert RP et al (2020) Impact of neoadjuvant durvalumab with or without tremelimumab on CD8(+) tumor lymphocyte density, safety, and efficacy in patients with oropharynx cancer: CIAO trial results. Clin Cancer Res 26(13):3211\u20133219. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-19-3977","journal-title":"Clin Cancer Res"},{"issue":"7726","key":"10663_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K et al (2018) The UK Biobank resource with deep phenotyping and genomic data. Nature 562(7726):203\u2013209. https:\/\/doi.org\/10.1038\/s41586-018-0579-z","journal-title":"Nature"},{"issue":"1","key":"10663_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12864-016-3391-x","volume":"18","author":"S Welsh","year":"2017","unstructured":"Welsh S, Peakman T, Sheard S, Almond R (2017) Comparison of DNA quantification methodology used in the DNA extraction protocol for the UK Biobank cohort. BMC Genomics 18(1):26. https:\/\/doi.org\/10.1186\/s12864-016-3391-x","journal-title":"BMC Genomics"},{"issue":"10","key":"10663_CR16","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/s41588-022-01187-9","volume":"54","author":"KA Jagadeesh","year":"2022","unstructured":"Jagadeesh KA, Dey KK, Montoro DT, Mohan R, Gazal S, Engreitz JM et al (2022) Identifying disease-critical cell types and cellular processes by integrating single-cell RNA-sequencing and human genetics. Nat Genet 54(10):1479\u20131492. https:\/\/doi.org\/10.1038\/s41588-022-01187-9","journal-title":"Nat Genet"},{"key":"10663_CR17","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.82705","volume":"12","author":"D Cheng","year":"2023","unstructured":"Cheng D, Qiu K, Rao Y, Mao M, Li L, Wang Y et al (2023) Proliferative exhausted CD8+ T cells exacerbate long-lasting anti-tumor effects in human papillomavirus-positive head and neck squamous cell carcinoma. Elife 12:e82705. https:\/\/doi.org\/10.7554\/eLife.82705","journal-title":"Elife"},{"issue":"4","key":"10663_CR18","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41588-023-01357-3","volume":"55","author":"SV Puram","year":"2023","unstructured":"Puram SV, Mints M, Pal A, Qi Z, Reeb A, Gelev K et al (2023) Cellular states are coupled to genomic and viral heterogeneity in HPV-related oropharyngeal carcinoma. Nat Genet 55(4):640\u2013650. https:\/\/doi.org\/10.1038\/s41588-023-01357-3","journal-title":"Nat Genet"},{"issue":"1","key":"10663_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27619-4","volume":"12","author":"CHL K\u00fcrten","year":"2021","unstructured":"K\u00fcrten CHL, Kulkarni A, Cillo AR, Santos PM, Roble AK, Onkar S et al (2021) Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing. Nat Commun 12(1):7338. https:\/\/doi.org\/10.1038\/s41467-021-27619-4","journal-title":"Nat Commun"},{"issue":"9","key":"10663_CR20","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa U, Claringbould A, Westra H-J, Bonder MJ, Deelen P, Zeng B et al (2021) Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet 53(9):1300\u20131310. https:\/\/doi.org\/10.1038\/s41588-021-00913-z","journal-title":"Nat Genet"},{"issue":"7982","key":"10663_CR21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, Chiou J, Traylor M, Benner C, Hsu YH, Richardson TG et al (2023) Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622(7982):329\u2013338. https:\/\/doi.org\/10.1038\/s41586-023-06592-6","journal-title":"Nature"},{"issue":"12","key":"10663_CR22","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL et al (2021) Large-scale integration of the plasma proteome with genetics and disease. Nat Genet 53(12):1712\u20131721. https:\/\/doi.org\/10.1038\/s41588-021-00978-w","journal-title":"Nat Genet"},{"issue":"11","key":"10663_CR23","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/jnnp-2023-331142","volume":"94","author":"WM Su","year":"2023","unstructured":"Su WM, Gu XJ, Dou M, Duan QQ, Jiang Z, Yin KF et al (2023) Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 94(11):954\u2013961. https:\/\/doi.org\/10.1136\/jnnp-2023-331142","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"383","key":"10663_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag1166","volume":"9","author":"C Finan","year":"2017","unstructured":"Finan C, Gaulton A, Kruger FA, Lumbers RT, Shah T, Engmann J et al (2017) The druggable genome and support for target identification and validation in drug development. Sci Transl Med 9(383):eaag1166. https:\/\/doi.org\/10.1126\/scitranslmed.aag1166","journal-title":"Sci Transl Med"},{"issue":"12","key":"10663_CR25","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1128\/mcb.23.12.4267-4282.2003","volume":"23","author":"S Hirabayashi","year":"2003","unstructured":"Hirabayashi S, Tajima M, Yao I, Nishimura W, Mori H, Hata Y (2003) JAM4, a junctional cell adhesion molecule interacting with a tight junction protein, MAGI-1. Mol Cell Biol 23(12):4267\u20134282. https:\/\/doi.org\/10.1128\/mcb.23.12.4267-4282.2003","journal-title":"Mol Cell Biol"},{"issue":"9","key":"10663_CR26","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1046\/j.1365-2443.2003.00673.x","volume":"8","author":"M Tajima","year":"2003","unstructured":"Tajima M, Hirabayashi S, Yao I, Shirasawa M, Osuga J, Ishibashi S et al (2003) Roles of immunoglobulin-like loops of junctional cell adhesion molecule 4; involvement in the subcellular localization and the cell adhesion. Genes Cells 8(9):759\u2013768. https:\/\/doi.org\/10.1046\/j.1365-2443.2003.00673.x","journal-title":"Genes Cells"},{"issue":"Pt 1","key":"10663_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1242\/jcs.00930","volume":"117","author":"K Ebnet","year":"2004","unstructured":"Ebnet K, Suzuki A, Ohno S, Vestweber D (2004) Junctional adhesion molecules (JAMs): more molecules with dual functions? J Cell Sci 117(Pt 1):19\u201329. https:\/\/doi.org\/10.1242\/jcs.00930","journal-title":"J Cell Sci"},{"issue":"2","key":"10663_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00281-014-0421-0","volume":"36","author":"AC Luissint","year":"2014","unstructured":"Luissint AC, Nusrat A, Parkos CA (2014) JAM-related proteins in mucosal homeostasis and inflammation. Semin Immunopathol 36(2):211\u2013226. https:\/\/doi.org\/10.1007\/s00281-014-0421-0","journal-title":"Semin Immunopathol"},{"key":"10663_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6661625","author":"Y Chen","year":"2021","unstructured":"Chen Y, Nie J, Li X, Fan T, Deng X, Liang D et al (2021) Identification of immune-related prognostic biomarkers associated with HPV-positive head and neck squamous cell carcinoma. J Immunol Res. https:\/\/doi.org\/10.1155\/2021\/6661625","journal-title":"J Immunol Res"},{"issue":"10","key":"10663_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-073375","volume":"13","author":"Z Lu","year":"2023","unstructured":"Lu Z, Zhou X, Fu L, Li Y, Tian T, Liu Q et al (2023) Prognostic prediction models for oropharyngeal squamous cell carcinoma (OPSCC): a protocol for systematic review, critical appraisal and meta-analysis. BMJ Open 13(10):e073375. https:\/\/doi.org\/10.1136\/bmjopen-2023-073375","journal-title":"BMJ Open"},{"issue":"6","key":"10663_CR31","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/lio2.982","volume":"7","author":"CDL Smith","year":"2022","unstructured":"Smith CDL, McMahon AD, Ross A, Inman GJ, Conway DI (2022) Risk prediction models for head and neck cancer: a rapid review. Laryngoscope Investig Otolaryngol 7(6):1893\u20131908. https:\/\/doi.org\/10.1002\/lio2.982","journal-title":"Laryngoscope Investig Otolaryngol"},{"issue":"4","key":"10663_CR32","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/aje\/kwz259","volume":"189","author":"YA Lee","year":"2020","unstructured":"Lee YA, Al-Temimi M, Ying J, Muscat J, Olshan AF, Zevallos JP et al (2020) Risk prediction models for head and neck cancer in the US population from the INHANCE consortium. Am J Epidemiol 189(4):330\u2013342. https:\/\/doi.org\/10.1093\/aje\/kwz259","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10663_CR33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/cej.0000000000000222","volume":"26","author":"YN Koyanagi","year":"2017","unstructured":"Koyanagi YN, Ito H, Oze I, Hosono S, Tanaka H, Abe T et al (2017) Development of a prediction model and estimation of cumulative risk for upper aerodigestive tract cancer on the basis of the aldehyde dehydrogenase 2 genotype and alcohol consumption in a Japanese population. Eur J Cancer Prev 26(1):38\u201347. https:\/\/doi.org\/10.1097\/cej.0000000000000222","journal-title":"Eur J Cancer Prev"},{"issue":"10","key":"10663_CR34","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1002\/ijc.34444","volume":"152","author":"S Budhathoki","year":"2023","unstructured":"Budhathoki S, Diergaarde B, Liu G, Olshan A, Ness A, Waterboer T et al (2023) A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers. Int J Cancer 152(10):2069\u20132080. https:\/\/doi.org\/10.1002\/ijc.34444","journal-title":"Int J Cancer"},{"issue":"3","key":"10663_CR35","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1200\/jco.21.01815","volume":"40","author":"E Bachy","year":"2022","unstructured":"Bachy E, Camus V, Thieblemont C, Sibon D, Casasnovas RO, Ysebaert L et al (2022) Romidepsin plus CHOP versus CHOP in patients with previously untreated peripheral T-cell lymphoma: results of the Ro-CHOP phase III study (conducted by LYSA). J Clin Oncol 40(3):242\u2013251. https:\/\/doi.org\/10.1200\/jco.21.01815","journal-title":"J Clin Oncol"},{"issue":"13","key":"10663_CR36","doi-asserted-by":"publisher","first-page":"7412","DOI":"10.26355\/eurrev_202007_21909","volume":"24","author":"M Herrera-Mart\u00ednez","year":"2020","unstructured":"Herrera-Mart\u00ednez M, Orozco-Samperio E, Monta\u00f1o S, Ariza-Ortega JA, Flores-Garc\u00eda Y, L\u00f3pez-Contreras L (2020) Vorinostat as potential antiparasitic drug. Eur Rev Med Pharmacol Sci 24(13):7412\u20137419. https:\/\/doi.org\/10.26355\/eurrev_202007_21909","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"13","key":"10663_CR37","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1158\/1078-0432.Ccr-20-4594","volume":"27","author":"SR Thibodeaux","year":"2021","unstructured":"Thibodeaux SR, Barnett BB, Pandeswara S, Wall SR, Hurez V, Dao V et al (2021) IFN\u03b1 augments clinical efficacy of regulatory T-cell depletion with denileukin diftitox in ovarian cancer. Clin Cancer Res 27(13):3661\u20133673. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-20-4594","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10663_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202102632","volume":"11","author":"Z Zhong","year":"2022","unstructured":"Zhong Z, Liu C, Xu Y, Si W, Wang W, Zhong L et al (2022) \u03b3-Fe(2)O(3) loading mitoxantrone and glucose oxidase for pH-responsive chemo\/chemodynamic\/photothermal synergistic cancer therapy. Adv Healthc Mater 11(11):e2102632. https:\/\/doi.org\/10.1002\/adhm.202102632","journal-title":"Adv Healthc Mater"},{"issue":"6","key":"10663_CR39","first-page":"1087","volume":"3","author":"J Garst","year":"2007","unstructured":"Garst J (2007) Topotecan: an evolving option in the treatment of relapsed small cell lung cancer. Ther Clin Risk Manag 3(6):1087\u20131095","journal-title":"Ther Clin Risk Manag"},{"issue":"13","key":"10663_CR40","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1158\/1078-0432.Ccr-07-5278","volume":"14","author":"P Correale","year":"2008","unstructured":"Correale P, Tagliaferri P, Fioravanti A, Del Vecchio MT, Remondo C, Montagnani F et al (2008) Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial). Clin Cancer Res 14(13):4192\u20134199. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-07-5278","journal-title":"Clin Cancer Res"},{"key":"10663_CR41","unstructured":"(2012) Aldesleukin. In: LiverTox\u00ae: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK547852\/"},{"issue":"5","key":"10663_CR42","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.bbmt.2017.01.077","volume":"23","author":"M Mustafa Ali","year":"2017","unstructured":"Mustafa Ali M, Abounader DM, Rybicki LA, Yurch MA, Starn J, Ferraro C et al (2017) Comparative effectiveness of busulfan and fludarabine versus fludarabine and 400 cGy total body irradiation conditioning regimens for acute myeloid leukemia\/myelodysplastic syndrome. Biol Blood Marrow Transplant 23(5):776\u2013781. https:\/\/doi.org\/10.1016\/j.bbmt.2017.01.077","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10391","key":"10663_CR43","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/s0140-6736(23)00727-4","volume":"401","author":"RK Kelley","year":"2023","unstructured":"Kelley RK, Ueno M, Yoo C, Finn RS, Furuse J, Ren Z et al (2023) Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 401(10391):1853\u20131865. https:\/\/doi.org\/10.1016\/s0140-6736(23)00727-4","journal-title":"Lancet"},{"issue":"6","key":"10663_CR44","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s41416-019-0394-9","volume":"120","author":"S Citro","year":"2019","unstructured":"Citro S, Bellini A, Miccolo C, Ghiani L, Carey TE, Chiocca S (2019) Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for \u0394Np63\u03b1. Br J Cancer 120(6):658\u2013667. https:\/\/doi.org\/10.1038\/s41416-019-0394-9","journal-title":"Br J Cancer"},{"key":"10663_CR45","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.oraloncology.2017.10.006","volume":"74","author":"Y Tao","year":"2017","unstructured":"Tao Y, Gross N, Liu Y, Zhang L, Li G, Huang Z et al (2017) A high ratio of IL-12R\u03b22-positive tumor-infiltrating lymphocytes indicates favorable prognosis in laryngeal cancer. Oral Oncol 74:148\u2013156. https:\/\/doi.org\/10.1016\/j.oraloncology.2017.10.006","journal-title":"Oral Oncol"},{"issue":"7","key":"10663_CR46","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1007\/s00405-021-07223-4","volume":"279","author":"X Le\u00f3n","year":"2022","unstructured":"Le\u00f3n X, Garc\u00eda J, Pujol A, de Juan J, V\u00e1squez R, Quer M et al (2022) Relationship between the transcriptional expression of PIM1 and local control in patients with head and neck squamous cell carcinomas treated with radiotherapy. Eur Arch Otorhinolaryngol 279(7):3679\u20133684. https:\/\/doi.org\/10.1007\/s00405-021-07223-4","journal-title":"Eur Arch Otorhinolaryngol"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10663-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-026-10663-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10663-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:58:41Z","timestamp":1791143921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-026-10663-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,4]]},"references-count":46,"alternative-id":["10663"],"URL":"https:\/\/doi.org\/10.1007\/s00405-026-10663-5","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,4]]},"assertion":[{"value":"22 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The current study was approved by the Ethics Committee on Biomedical Research, West China Hospital, Sichuan University (WCH No. 2019\u2013357, issued on July 18,2019). Analysis using the UK Biobank data was performed under the generic ethical approval obtained by the UK Biobank from the North West Multi-centre Research Ethics Committee (REC reference: 21\/NW\/0157, June 29,2021). Other used data were approved by corresponding ethical committee detailed in original publications.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u00a0The funding organization had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the decision to submit the article for publication; or in the preparation, review, or approval of the article.\u00a0","order":2,"name":"Ethics","label":"\u00a0Sponsor's Role","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Authors declare that there is no conflict of interest. The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","label":"Conflicting interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}